![]() Quantum BioPharma Quantum BioPharma (formerly known as FSD Pharma) is a biotech company focused on the development of indoor-grown pharmaceutical-grade cannabis. | AusCann AusCann is a pharmaceutical company focused on the development, production, and distribution of cannabinoid-based medicines. | ![]() Skye Bioscience Skye Bioscience (formerly Nemus Bioscience, Emerald Bioscience) is a biopharmaceutical company. | ![]() TTS Pharma TTS Pharma acquires, develops, and blends technologies to enable the pharmacogenetic stratification of patients and accurate prescriptive treatment via transdermal drug delivery. | |
Founding Date | Founding Date 1994 | Founding Date 2013 | Founding Date 2012 | Founding Date 2012 |
Type | Type Public | Type Public | Type Public | Type Private |
Tags | ||||
Locations | Locations Toronto, CA HQ | Locations Wangara, AU HQ | Locations Long Beach, US HQ San Diego, US | Locations Liverpool, GB HQ |
Employees | Employees 853% decrease | Employees N/A | Employees 3 | Employees 4 |
Valuation ($) | Valuation ($) 66.7 k | Valuation ($) 12 m | Valuation ($) 22.5 m | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $1.3m (FY, 2023) | Gross profit N/A | Gross profit N/A |
Net income | Net income ($27m) (FY, 2025) | Net income ($10.9m) (FY, 2023) | Net income ($55.9m) (FY, 2025) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised $ 7.7m | Total funding raised N/A | Total funding raised $ 20m | Total funding raised $ 13.9m |
AusCann is a pharmaceutical company focused on the development, production, and distribution of cannabinoid-based medicines.
View company
Skye Bioscience (formerly Nemus Bioscience, Emerald Bioscience) is a biopharmaceutical company.
View company
TTS Pharma acquires, develops, and blends technologies to enable the pharmacogenetic stratification of patients and accurate prescriptive treatment via transdermal drug delivery.
View company